JW Partners’ Jason Wild Talks Cannabis, TerrAscend, Stock Picks With Barron’s

Jason Wild, CEO of JW Asset Management LLC, is one of the most seasoned U.S. institutional investors in legal cannabis. 

The former pharmacist, who oversees $1 billion in assets, recently chatted with Barron’s about his fund.

“From 1998 to 2010, the fund was up 22% annualized, net of fees,” he explained, revealing that they “grew assets from $89,000 to $25.5 million.”

Buy What You Know

Before venturing into the cannabis industry, Wild utilized the “buy what you know” approach. 

His fund bought Arbor Pharmaceuticals in 2010 for $2.5 million in cash. By the next year, it “had $127 million in sales and $55million in Ebitda,” disclosed Wild.

In 2014, they sold a third …

Full story available on Benzinga.com

More JW Partners' Jason Wild Talks Cannabis, TerrAscend, Stock Picks With Barron's